Romero, Jaclyn .
HRN: 18-31-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/30/2024
03/31/2024
IV
500 Mg
Q8 X 3 Doses
SP NSVD; IUFD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes